NLS Pharmaceutics AG Interest Expense 2011-2026 | NLSP

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense NLS Pharmaceutics AG

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
49.4 K	-220 K	10 K	48.1 K	-328 K	-65.4 K	16 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
49.4 K	-328 K	-70 K